Compare ClearPoint Neuro Inc (CLPT) vs Nuscale Power Corporation (SMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Nuscale Power Corporation — how do they compare? ClearPoint Neuro Inc trades at $15.91 (market cap $478.63M), while Nuscale Power Corporation trades at $8.43 (market cap $2.98B). The key difference: Nuscale Power Corporation is far larger — about 6.2× ClearPoint Neuro Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals.
| CLPT | SMR | |
|---|---|---|
Market Cap | $478.63M | $2.98B |
Sector | Health | Utilities |
52-Week High | $29.60 | $53.43 |
52-Week Low | $8.66 | $8.36 |
Enterprise Value | $506.63M | $2.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $16.51, down 5.66% on the day, with a bullish technical signal from moving averages but negative profitability. The company reported record Q1 2026 revenue of $36.97M with 25% organic device growth, though it missed EPS estimates with a $0.32 loss. Recent FDA clearance for the Velocity Alpha surgical drill and a partnership with Sungkyunkwan University highlight expansion efforts in neurosurgical navigation and drug delivery.
Outlook remains speculative with 100% analyst buy ratings anticipating gene therapy commercialization upside, but high execution and regulatory risks persist amid consistent losses and negative margins. The stock's valuation at 11.31x sales reflects growth expectations, yet cash burn from operations requires careful monitoring of financing sustainability.
NuScale Power (SMR) trades at $8.36, down 7.42% in the last session and near its 52-week low. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal significant challenges including negative net income margins (-2,066.55%) and declining revenue projections. Recent news highlights the company's unique position as the only US company with certified small modular reactor design approval, though commercialization timelines remain uncertain.
Despite analyst consensus pointing to 46% upside potential with a $12.25 price target, SMR faces substantial execution risks. The company must demonstrate commercial viability of its reactor technology while managing cash burn. Long-term potential exists in nuclear energy's AI-driven demand surge, but near-term profitability remains elusive with projected losses through 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →
